Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Exploring Healthy Lifestyles for Bipolar Disorder in the Bay Area

Official title: Time-restricted Eating as an Adjunctive Intervention for Bipolar Disorder

Run by University of California, Berkeley · NCT06555406 · Data updated 2026-11-12

This study is testing if following a time-restricted eating plan for eight weeks can help people with bipolar disorder feel better and improve their sleep and mood.

More Bipolar Disorder trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity of California, Berkeley
Academic / other
Locations1 site (Berkeley, California)
StatusRecruiting
StartedNovember 22, 2024
Main results expectedFebruary 1, 2029
Study endsFebruary 1, 2029
Registry record updatedJanuary 14, 2026
Trial IDNCT06555406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with bipolar I or II disorder who are currently receiving medication and have sleep or circadian rhythm concerns.

Probably not a fit

Patients without bipolar disorder or those not experiencing sleep or circadian issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates how adherence to time-restricted eating (TRE) affects diurnal rhythms and symptoms of bipolar disorder. Participants, who are already receiving medication for bipolar disorder and experiencing sleep or circadian issues, will follow a TRE regimen for eight weeks while completing daily measures of eating, sleep, and mood. The study aims to assess changes in manic and depressive symptoms, as well as improvements in quality of life, through the evaluation of clock gene expression and other health markers. Data will be collected at baseline, during, and after the intervention to understand the potential benefits of TRE in managing bipolar disorder.

Why it matters

Potential benefit: If successful, this study could provide insights into how time-restricted eating may improve mood stability and quality of life for patients with bipolar disorder.

How similar studies have gone: While the specific approach of combining TRE with bipolar disorder management is novel, related studies on dietary interventions have shown promising results in mood regulation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Meets diagnostic criteria for bipolar I disorder or bipolar II disorder (but not cyclothymia, bipolar disorder Not otherwise specified or bipolar disorder due to another medical condition) assessed by the Diagnostic Interview for Anxiety, Mood, and Obsessive-compulsive and Related Neuropsychiatric Disorders \[DIAMOND\])
* current sleep (insomnia, hypersomnolence) or circadian sleep-wake (delayed phase, advanced phase, irregular sleep-wake, non-24-hour sleep-wake-type) concerns indicated by endorsement of at least some sleep or circadian-related impairment across the screening self-reports or interview
* Living in an English-speaking country (and one that the researchers have expertise in research procedures and diet)
* Has been speaking English for at least 10 years, speaks English in the home, or certifies that they are able to understand English well for the study and demonstrates this during the screening interview.
* Receiving medical care for bipolar disorder (referrals will be provided for those who would like to begin care)
* Mood-stabilizing medication regimens stable for at least one month
* \< 5 kg weight change in the past 3 months
* Currently eating ≥ 12 hours per day at least twice per week
* Able to operate the camera function and respond to web-based surveys by phone (loaner phones will be provided as needed)
* Not engaged in current shift work or have other responsibilities such as providing care that would chronically disrupt their sleep (i.e., \> 3 h between 22:00 and 05:00 h for at least 1 day/week)
* Able to complete 7 days of dietary logs adequately (e.g., at least 2 entries per day, covering at least a 5-hour eating window) during the baseline period
* Able to complete screening and baseline questionnaires adequately (e.g., not failing more than 1 attention check item with instructed responding; responding to standard multiple-choice items in a mean of \< 2 seconds per item). Where individuals respond to more than 14 items in a row with the same response, their answers will be manually reviewed for possible invalidity.

Exclusion criteria include the following:

* Current episode of depression, hypomania or mania, or psychosis (assessed by the DIAMOND), Participants with acute mood disorder episodes will be encouraged to seek treatment and to consider the study when symptoms have remitted.
* Eating disorder diagnosis (by self-report of treatment or diagnosis at any point during their life, Short Eating Disorder Examination Questionnaire (EDE-QS) scores above clinical concern thresholds for eating disorders, or DIAMOND interview of symptoms during adulthood)
* Past 3-month alcohol use disorder or substance use disorder (assessed by DIAMOND)
* Active suicidal ideation coupled with plan, intent or attempt history as assessed by Columbia Suicide Severity Rating Scale
* Conditions that would interfere with ability to take part in the intervention, including pregnancy, breastfeeding, uncorrected hypo or hyperthyroidism, gastrointestinal conditions impairing nutrient absorption
* Conditions that would confound immune or other study measures, such as HIV, AIDS, lupus, or multiple sclerosis
* Medications contraindicated for fasting: clozapine, glucose-lowering medications, diabetes-related injections, medications requiring food early morning or late evening, corticosteroids; Glucagon-like peptide-1 (GLP-1) agonists will not be an exclusion criteria if weight stabilized
* Cognitive deficits as noted during the initial interview or as indicated by low performance on the Orientation Memory Concentration Test- Short Version (weighted score \< 20)

Where it's running

  • University of California Berkeley
    Berkeley, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.